InvestorsHub Logo
Followers 138
Posts 22949
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Thursday, 04/11/2024 2:05:32 PM

Thursday, April 11, 2024 2:05:32 PM

Post# of 459317
Catalyst for increasing the price of AVXL stock in the NEAR FUTURE

Alzheimer’s disease: Data from the blarcamesine Phase 2b/3 ANAVEX®2-73-AD-004 trial to be published in an upcoming peer-reviewed journal

Alzheimer’s disease: Full regulatory submission of blarcamesine in Europe (EMA)

Parkinson’s disease: Initiation of ANAVEX®2-73 imaging- focused trial and Phase 2b/3 6 months trial

Fragile X: Initiation of potentially pivotal ANAVEX®2-73 Phase 2/3 clinical trial

New Rare disease: Initiation of potentially pivotal ANAVEX®2-73 Phase 2/3 clinical trial

Publications: Continued clinical publications involving ANAVEX®2-73 and ANAVEX®3-71

Good luck and GOD bless,
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News